Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Daniela Gallo

12PUBLICATIONS
23CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

Sort by Publication Date:
|Oct 21, 2024
Author Correction: The interaction of β-arrestin1 with talin1 driven by endothelin A receptor as a feature of α5β1 integrin activation in high-grade serous ovarian cancer.

Ilenia Masi, Flavia Ottavi, Danila Del Rio

|May 16, 2023
Exploring the Control of PARP1 Levels in High-Grade Serous Ovarian Cancer.

Giuseppina Raspaglio, Marianna Buttarelli, Natalia Cappoli

|Jan 30, 2023
The interaction of β-arrestin1 with talin1 driven by endothelin A receptor as a feature of α5β1 integrin activation in high-grade serous ovarian cancer.

Ilenia Masi, Flavia Ottavi, Danila Del Rio

|Oct 14, 2022
What's beyond BRCA Mutational Status in High Grade Serous Ovarian Cancer? The Impact of Hormone Receptor Expression in a Large BRCA-Profiled Ovarian Cancer Patient Series: A Retrospective Cohort Study.

Emanuele Perrone, Riccardo Tudisco, Pia Clara Pafundi

|Jun 15, 2022
Preclinical models of epithelial ovarian cancer: practical considerations and challenges for a meaningful application.

Alessandra Ciucci, Marianna Buttarelli, Anna Fagotti

|Feb 05, 2022
Identification of a novel gene signature predicting response to first-line chemotherapy in BRCA wild-type high-grade serous ovarian cancer patients.

Marianna Buttarelli, Alessandra Ciucci, Fernando Palluzzi

Pageof 2

Frequent Collaborators

2 joint publications

Laura Rosanò

2 joint publications

Francesca Spadaro

2 joint publications

Anna Bagnato

1 joint publications

Natalia Cappoli

1 joint publications

Fabiola Moretti

1 joint publications

Gabriele Babini

1 joint publications

Tina Pasciuto

1 joint publications

Geny Piro

1 joint publications

Luca Boldrini

1 joint publications

Alfredo Cesario

Frequent Collaborators

2 joint publications

Laura Rosanò

2 joint publications

Francesca Spadaro

2 joint publications

Anna Bagnato

1 joint publications

Natalia Cappoli

Top Related Videos

<em>In vitro</em> Mesothelial Clearance Assay that Models the Early Steps of Ovarian Cancer Metastasis
08:54

<em>In vitro</em> Mesothelial Clearance Assay that Models the Early Steps of Ovarian Cancer Metastasis

Published on : Feb 17, 2012

14.4K
Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids <em>via</em> Immunofluorescence Assays
04:07

Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids <em>via</em> Immunofluorescence Assays

Published on : Feb 24, 2023

1.8K
See more related videos

Top Related Videos

<em>In vitro</em> Mesothelial Clearance Assay that Models the Early Steps of Ovarian Cancer Metastasis
08:54

<em>In vitro</em> Mesothelial Clearance Assay that Models the Early Steps of Ovarian Cancer Metastasis

Published on : Feb 17, 2012

14.4K
Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids <em>via</em> Immunofluorescence Assays
04:07

Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids <em>via</em> Immunofluorescence Assays

Published on : Feb 24, 2023

1.8K
See more related videos